UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - 28 Feb 2024 Form 3 Insider Report for Aileron Therapeutics, Inc. (RNTX)

Role: 10%+ Owner
Signature: /s/ Joan Moeller, Chief Operating Officer
Issuer symbol: RNTX
Transactions as of: 28 Feb 2024
Net transactions value: $0
Form type: 3
Filing time: 30 Apr 2024, 15:32:13 UTC
Previous filing: 02 Jun 2023
Next filing: 14 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ALRN	Common Stock						1,810,457	28 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALRN	Warrant							28 Feb 2024	Common Stock	2,170	$5.76	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.

Content

Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.